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Streptococcus pneumoniae (pneumococcus) is gram-
positive, α-hemolytic, aerobic, encapsulated diplococ-
cus. It is one of the most important causative agent of 
pneumonia, meningitis, bacteremia, sinusitis, and otitis 
media. In 2005, WHO estimated that 1.6 million peo-
ple die of pneumococcal disease every year; 0.7-1 mil-
lion of them are children aged < 5 years, most of whom 
live in developing countries. In the developed world, 
children aged < 2 years and elderly people carry the 
major burden of disease. Clinical conditions associated 
with immune deficiency increase the likelihood of con-
tracting pneumococcal disease. Moreover the growing 
resistance of Streptococcus pneumoniae to commonly 
used antibiotics underlines the urgent need for vaccines 
to be used to control pneumococcal disease.
Pneumococcus may be harbored in the upper respira-
tory tract particularly in children with a rate of colo-
nization of about 60% in children in winter and early 
spring, and 2% in adults. 
The clinical signs and symptoms of pneumococcal 
infections cannot be differentiated from a disease of 
alternative etiology so the diagnosis of Streptococcus 
pneumoniae infection is frequently a problem.
The “gold standard” diagnostic method is still culture, 
but good-quality samples are not always available. 
Furthermore, cultures are not infrequently negative in 
infections considered likely on clinical grounds to be 
of pneumococcal origin, particularly after antibiotic 
administration [1, 2].
The laboratory diagnosis of pneumococcal infections 
currently is based on methods already used for many 
decades. The first step of investigation is the gram-
stained smears of clinical specimens. Gram-positive 
cocci arranged as pairs of lanceolate-shaped cells can 
be observed. 
Specimens that may be expected to yield pneumococci 
on culture should be plated onto a sheep blood agar or 
chocolate agar. After overnight incubation at 35° C with 
5% CO2, Streptococcus pneumoniae shows a spectrum 
of colony types related to the degree of encapsulation 
generally surrounded by a large zone of green alpha-
hemolysis, caused by a partial lysis of the erythrocytes. 
Heavily encapsulated strains develop colonies several 
millimeters in diameter, mucoid, gray, similar to drops 
of oil on the agar surface. Less encapsulated strains 
appear smaller. On prolonged incubation the central 
portion of the colony may collapse giving the charac-
teristic “checker piece” appearance. Susceptibility to 
optochin (ethylhydrocupreine) and bile solubility are 
used to differentiate Streptococcus pneumoniae from 
the other viridans streptococci. Optochin is an antibac-
terial agent not used in therapy but only for the dif-
ferentiation of streptococci. Usually pneumococci are 
optochin susceptible though optochin resistant strains 
are described [3]. The bile solubility test, based on the 
autolysis of Streptococcus pneumoniae in the presence 
of the surfactant sodium deoxycholate, is considered as 
being very sensitive and specific for identification of 
pneumococci.
The Quellung reaction is a more specific method for 
pneumococcal detection from pure cultures or sputum 
samples. After reaction of the pneumococcus with 
streptococcal anticapsular antisera, the pneumococcal 
capsule becomes visually enhanced, and the bacterial 
cell appears to be surrounded by a halo. While this re-
action is considered specific for pneumococcus, cross 
reaction reported with other streptococcal polysac-
charides will produce false negative results [4, 5]. The 
laboratory investigation must take into account the site 
of infection: respiratory tract, middle ear, central nerv-
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ous system, eye, blood, bones and joints are sites where 
pneumococcus can be potentially associated with the 
disease.
The isolation of Streptococcus pneumoniae from blood 
culture define diagnosis of pneumococcal disease how-
ever rates of positive blood culture results for adults 
hospitalized with pneumonia are only 3%-8% [6] and 
are lower in children [7]. Bacteremia in pneumococcal 
meningitis occurs more frequently than in pneumonia 
(> 50%) [8].
Low density of the microorganism in blood, prior ad-
ministration of antimicrobials, the intermittent blood-
stream invasion, the bacterial autolysin released during 
the stationary growth phase, contamination of blood 
samples and cultures, insufficient volume, incorrect 
ratios of blood to broth, delays in transporting blood 
culture bottles to the laboratory, delays in performing 
subcultures of blood cultures, explain why the tradi-
tional methods of bacterial growth on media often 
fail [9]. Nevertheless the expert group for the diagno-
sis of pneumococcal pneumonia recommend that blood 
culture should be used, when available, because it can 
provide a specific aetiological diagnosis. In this situa-
tion the diagnosis of pneumococcal pneumonia is chal-
lenging. The utility of sputum Gram stain and culture 
is variable and is influenced by the ability of the patient 
to produce a good specimen, laboratory screening prac-
tices, and administration of antimicrobial drugs before 
the collection of specimens. On the other hand ideal di-
agnostic tests should not necessarily rely on the culture 
of viable organisms, must have high specificity and 
sensitivity, and should not be affected by prior antibi-
otic treatment. In addition, they should be inexpensive 
and easy to use without extensive training. In this con-
text the development of an immunochromatographic 
test that detects the C polysaccharide cell wall antigen, 
common to all strains of Streptococcus pneumoniae, in 
urine (BinaxNOW, Binax, Portland, Maine), have im-
proved the rapid diagnostic tools. It has a sensitivity of 
70%-80% and a specificity of > 90%, compared with 
conventional diagnostic methods for detection of pneu-
mococcal pneumonia in adults [10-12]. 
However the assay lacks specificity in children, be-
cause it can give positive results in healthy children 
with carriage of pneumococci and of other closely re-
lated Streptococcus species [13].
This assay has been successfully used with specimens 
of other body fluids, particularly for the rapid diagnosis 
of pneumococcal meningitis with use of CSF samples, 
with a sensitivity of 95%-100% and a specificity of 
100% [14]. It has also been successfully used with pleu-
ral fluid specimens obtained from children and adults 
with pneumonia [15]. New assays based on the detec-
tion of other pneumococcal targets in urine samples are 
studied. For example the putative proteinase matura-
tion protein A (PpmA) of Streptococcus pneumoniae 
is homologous to members of the family of peptidyl-
prolyl cis–trans isomerases (PPIases), which accelerate 
the rate-limiting cis-trans or trans-cis conformational 
changes at X-Pro bonds during protein folding. The 
protein is a surface-located immunogenic lipoprotein 
that contributes to bacterial virulence. In literature is 
reported that the kidney barrier in patients with pneu-
mococcal infection is permeable to the Streptococcus 
pneumoniae protein PpmA, resulting in its excretion 
in urine, which can be detected. At the moment more 
studies are required to be validated [16].
Nucleic acid amplification tests, such as PCR, are im-
portant diagnostic tools. They can detect small amounts 
of nucleic acid from potentially all pathogens, they do 
not depend on the viability of the target microbe, they 
are not affected by prior antimicrobial therapy and they 
provide results within a short time frame. LytA (au-
tolysin) and Pneumolysin gene (ply) are genes target 
more used. LytA PCR has been shown to be more sen-
sitive than detection of polysaccharide in urine [17], 
while Ply PCR is not specific and shows cross-reac-
tions with other streptococcal species. The gene target 
is important, but the segment of the gene targeted is 
more important, owing to allelic variation in the target 
gene between closely related species [18]. 
In the etiologic diagnosis of pneumonia, PCR has a 
sensitivity for detecting Streptococcus pneumoniae in 
blood samples ranging from 29% to 100% [19]. The 
limits of molecular tests in blood samples may be ex-
plained by the rapid clearance of the Streptococcus 
pneumoniae from the blood stream and by sampling 
errors. Moreover positive pneumococcal PCR results 
have also been recorded from asymptomatic sub-
jects [20] and these findings could be related to tempo-
rary bacteremia.
Regarding sputum samples, reported PCR positivity 
rates have ranged from 68% to 100% for samples from 
patients with pneumonia [19], although the coloniza-
tion of the upper respiratory tract could affect the re-
sults. Moreover the presence of the pneumolysin gene 
in some nonpneumococcal viridans streptococci rep-
resents a problem of cross-reactivity [21]. Unlike for 
pneumococcal pneumonia, detection of pneumococcal 
DNA in CSF specimens can be useful for diagnosis 
of pneumococcal meningitis with high sensitivity and 
specificity (92%-100% and 100%, respectively) [22]. 
Matrix-assisted laser desorption ionization time-of-
flight mass spectrometry (MALDI-TOF MS) is start-
ing to be used in clinical microbiology laboratories for 
routine bacterial identification from colonies.
Mass spectrometry (MS), a rapid, powerful, and sen-
sitive analytical tool has been used recently for the 
differentiation, identification, and characterization of 
microbial pathogens. In particular, MALDI-TOF have 
been used to analyze whole bacterial cells that have 
not been modified chemically or by mechanical disrup-
tion [23]. By use of this technique protein/peptide fin-
gerprints can be generated based on a proteomic profile 
and these patterns could serve as protein biomarkers 
that may prove useful for diagnostic purposes. Pro-
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teomic profiling is an alternative to biochemical and 
genome-based identification schemes. MALDI-TOF 
MS has also been used for diagnosis on positive blood 
cultures. This technology is promising, as it reduces 
the cost and time to result of bacterial identification. 
However, the performance of MALDI-TOF MS for 
Streptococcus spp. is generally weak, and further stud-
ies are required to improve differentiation between 
Streptococcus pneumoniae and closely related viridans 
species such as Streptococcus mitis [24, 25].
Conclusions
Medical bacteriological investigation is based on five 
steps: inoculation of the specimen, incubation, reading 
the plates, identification and susceptibility testing. The 
question is how well these steps have been performed 
and how they can be improved for optimal identifi-
cation and characterization of the major respiratory 
pathogens. New technologies for specimen process-
ing, marker detection and typing (mass spectrometry, 
microarrays, and sequencing) could facilitate the im-
plementation of diagnostics in laboratories. However 
the use of a combination of assays in parallel must be 
carefully evaluated, including cost-effectiveness as-
pects. PCR is the best known and most implemented 
diagnostic molecular technology to date. It can detect 
specific infectious agents and determine their virulence 
and antimicrobial genotypes with greater speed, sen-
sitivity and specificity than conventional microbiol-
ogy methods. Bacteriological diagnosis is continually 
advancing, particularly in the areas of proteomics and 
genomics. Matrix-assisted laser desorption ionization-
time-of-flight (MALDI-TOF) and electrospray ioniza-
tion (ESI) mass spectrometry (MS) and tandem mass 
spectrometry (MS-MS) have been at the core of these 
developments even if further studies are required to im-
prove the differentiation between Streptococcus pneu-
moniae and related viridans species. 
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